Blog
Investors Heavily Search ARKO Corp. (ARKO): Here is What You Need to Know
ARKO Corp. (ARKO) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Shares
Is Most-Watched Stock Marathon Petroleum Corporation (MPC) Worth Betting on Now?
Marathon Petroleum (MPC) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the
CMS Energy Q1 Earnings Beat Estimates, Revenues Increase Y/Y
CMS Energy Corporation CMS reported first-quarter 2026 earnings per share (EPS) of $1.13, which beat the Zacks Consensus Estimate of $1.11 by 1.8%. The bottom line also increased 10.8% from $1.02 in
Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
These 2 Construction Stocks Could Beat Earnings: Why They Should Be on Your Radar
Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.
Life and
Want Better Returns? Don't Ignore These 2 Computer and Technology Stocks Set to Beat Earnings
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.
The
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
Recent Price Trend in Forum Energy (FET) is Your Friend, Here's Why
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
How to Boost Your Portfolio with Top Utilities Stocks Set to Beat Earnings
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the
Commvault Systems (CVLT) Beats Q4 Earnings and Revenue Estimates
Commvault Systems (CVLT) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.09 per share. This compares to earnings of $1.03 per share a year ago. These
Here's Why Momentum in Gorman-Rupp (GRC) Should Keep going
While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure
Here Is Why Bargain Hunters Would Love Fast-paced Mover First American Financial (FAF)
Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and
Stryker to Report Q1 Earnings: What's in Store for the Stock?
Stryker Corporation SYK is scheduled to release first-quarter 2026 results on April 30, after market close. In the last reported quarter, the company delivered an earnings surprise of 1.59%.
Q1
Nucor Q1 Earnings and Revenues Top on Higher Volumes and Prices
Nucor Corporation NUE reported earnings of $3.23 per share for the first quarter of 2026, up from 67 cents in the year-ago quarter. It beat the Zacks Consensus Estimate of $2.79.
The company
Stock Market News for Apr 28, 2026
Wall Street closed mixed on Monday, pulled up by tech and financial stocks. Investor sentiment was cautious ahead of the key Fed meeting and a heavy week of Big Tech earnings, even as rising oil
Watsco (WSO) Q1 Earnings and Revenues Surpass Estimates
Watsco (WSO) came out with quarterly earnings of $1.87 per share, beating the Zacks Consensus Estimate of $1.73 per share. This compares to earnings of $1.93 per share a year ago. These figures are
Kiniksa Pharmaceuticals International, plc (KNSA) Tops Q1 Earnings and Revenue Estimates
Kiniksa Pharmaceuticals International, plc (KNSA) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.11 per
Wave Life Sciences (WVE) Reports Q1 Loss, Beats Revenue Estimates
Wave Life Sciences (WVE) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to a loss of $0.29 per share a year ago. These
Hope Bancorp (HOPE) Q1 Earnings Surpass Estimates
Hope Bancorp (HOPE) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.19 per share a year ago. These
Are Options Traders Betting on a Big Move in Akebia Therapeutics Stock?
Investors in Akebia Therapeutics, Inc. AKBA need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 18, 2026 $4 Call had some of the highest


